This is the current release of the guideline.

Pathogenesis

Recommendations

• Use a central venous catheter (CVC) with the minimum number of ports or lumens essential for the management of the patient.
• Use totally implantable access devices for patients who require long-term, intermittent vascular access. For patients requiring frequent or continuous access, a peripherally inserted central catheter (PICC) or tunneled CVC is preferable.

Site of Catheter Insertion

Recommendations

• Weigh the risks and benefits of placing a device at a recommended site to reduce infectious complications against the risk for mechanical complications (e.g., pneumothorax, subclavian artery puncture, subclavian vein laceration, subclavian vein stenosis, hemothorax, thrombosis, air embolism, and catheter misplacement).
• Use a subclavian site (rather than a jugular or femoral site) in adult patients to minimize infection risk for nontunneled CVC placement.
• No recommendation can be made for a preferred site of insertion to minimize infection risk for a tunneled CVC.
• Place catheters used for hemodialysis and pheresis in a jugular or femoral vein rather than a subclavian vein to avoid venous stenosis if catheter access is needed.

Aseptic Technique

Recommendations

• Use aseptic technique including the use of a cap, mask, sterile gown, sterile gloves, and a large sterile sheet for the insertion of CVCs (including PICCs) or guide-wire exchange.
• Although a 2% chlorhexidine-based preparation is preferred, tincture of iodine, an iodophor, or 70% alcohol may be used. Allow the antiseptic to remain on the insertion site and to air dry before catheter insertion. Allow povidone iodine to remain on the skin for at least 2 minutes, or longer if it is not yet dry before insertion.

Antimicrobial- or Antiseptic-Impregnated Catheters and Cuffs

Recommendations

• Use an antimicrobial- or antiseptic-impregnated CVC in adults whose catheter is expected to remain in place >5 days if, after implementing a comprehensive strategy to reduce rates of catheter-related blood stream infections (CR-BSI), the CR-BSI rate remains above the goal set by the individual institution based on benchmark rates and local factors.

Catheter Fixation and Dressing

Recommendations

• Do not use topical antibiotic ointment or creams on insertion sites (except when using dialysis catheters) because of their potential to promote fungal infections and antimicrobial resistance.
• Tunneled CVC sites that are well healed may not require dressings.

Central Venous Catheter Replacement

Recommendations

• Do not routinely replace CVCs, PICCs, hemodialysis catheters, or pulmonary artery catheters to prevent catheter-related infections.
• Do not remove CVCs or PICCs on the basis of fever alone. Use clinical judgment regarding the appropriateness of removing the catheter if infection is evidenced elsewhere or if a noninfectious cause of fever is suspected.
• Do not use guide-wire techniques to replace catheters in patients suspected of having catheter-related infection.

Hemodialysis Catheters

Hemodialysis catheters should be avoided in favor of arteriovenous fistulas and grafts. If temporary access is needed for dialysis, a cuffed catheter is preferable to a noncuffed catheter if the catheter is expected to stay in place for longer than 3 weeks.

Recommendations

• Use a cuffed CVC for dialysis if the period of temporary access is anticipated to be prolonged (e.g., >3 weeks).

Central Venous Catheters in Children

Because of the limited vascular sites in children, attention should be given to the frequency with which catheters are replaced in these patients. In a study in which survival analysis techniques were used to examine the relationship between the duration of central venous catheterization and complications in pediatric patients in the ICU, all patients studied (n = 397) remained without infection for a median of 23.7 days. In addition, no relationship was found between duration of catheterization and the daily probability of infection (r = 0.21, P = .1), suggesting that routine replacement of CVCs likely does not reduce the incidence of catheter-related infection.

None provided

The type of evidence supporting the recommendations is not specifically stated. See the original guideline document for selected supporting data, background information, and references.

This guideline is adapted from the following source:

Centers for Disease Control. Guidelines for the prevention of intravascular catheter-related infections. MMWR Morb Mortal Wkly Rep 2002; 51 (No.RR 10):1–36.

2003 Sep

Society of Interventional Radiology - Medical Specialty Society

Society of Interventional Radiology

Standards of Practice Committee

Primary Authors: Donald L. Miller, MD; Naomi P. O’Grady, MD

Not stated

This is the current release of the guideline.

None available

None available

This NGC summary was completed by ECRI on October 18, 2004.

This summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions.